These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26088214)

  • 21. Neuroendocrine immunology of fibromyalgia.
    Di Franco M; Iannuccelli C; Valesini G
    Ann N Y Acad Sci; 2010 Apr; 1193():84-90. PubMed ID: 20398012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms.
    Clauw DJ; Chrousos GP
    Neuroimmunomodulation; 1997; 4(3):134-53. PubMed ID: 9500148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia.
    Staud R; Spaeth M
    CNS Spectr; 2008 Mar; 13(3 Suppl 5):12-7. PubMed ID: 18323768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysfunctional syndromes and fibromyalgia: a 2012 critical digest.
    Sarzi-Puttini P; Atzeni F; Di Franco M; Buskila D; Alciati A; Giacomelli C; Rossi A; Bazzichi L
    Clin Exp Rheumatol; 2012; 30(6 Suppl 74):143-51. PubMed ID: 23261014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CENTRALIZED PAIN AND FIBROMYALGIA: WHAT DO WE MEAN WHEN WE SAY "IT'S ALL IN YOUR HEAD"?].
    Ablin JN
    Harefuah; 2017 Dec; 156(12):762-766. PubMed ID: 29292613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the common expression of neuroendocrine hormones and cytokines in the immune and central nervous systems.
    Farrar WL
    Brain Behav Immun; 1988 Dec; 2(4):322-7. PubMed ID: 3076482
    [No Abstract]   [Full Text] [Related]  

  • 27. Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: new concepts in treatment.
    Gur A; Oktayoglu P
    Curr Pharm Des; 2008; 14(13):1274-94. PubMed ID: 18537652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of involvement of central neural mechanisms in generating fibromyalgia pain.
    Staud R
    Curr Rheumatol Rep; 2002 Aug; 4(4):299-305. PubMed ID: 12126581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immune system as the sixth sense.
    Blalock JE
    J Intern Med; 2005 Feb; 257(2):126-38. PubMed ID: 15656872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibromyalgia syndrome pathology and environmental influences on afflictions with medically unexplained symptoms.
    Albrecht PJ; Rice FL
    Rev Environ Health; 2016 Jun; 31(2):281-94. PubMed ID: 27105483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bidirectional communication between the brain and the immune system: implications for physiological sleep and disorders with disrupted sleep.
    Lorton D; Lubahn CL; Estus C; Millar BA; Carter JL; Wood CA; Bellinger DL
    Neuroimmunomodulation; 2006; 13(5-6):357-74. PubMed ID: 17709958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal and Hepatic Disease in Fibromyalgia.
    Schatz RA; Moshiree B
    Rheum Dis Clin North Am; 2018 Feb; 44(1):131-142. PubMed ID: 29149921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of disease: pain in fibromyalgia syndrome.
    Staud R; Rodriguez ME
    Nat Clin Pract Rheumatol; 2006 Feb; 2(2):90-8. PubMed ID: 16932662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic syndromes and chronic pain in women with overactive bladder.
    Reynolds WS; Mock S; Zhang X; Kaufman M; Wein A; Bruehl S; Dmochowski R
    Neurourol Urodyn; 2017 Apr; 36(4):1113-1118. PubMed ID: 27367486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversation galante: how the immune and the neuroendocrine systems talk to each other.
    Di Comite G; Grazia Sabbadini M; Corti A; Rovere-Querini P; Manfredi AA
    Autoimmun Rev; 2007 Nov; 7(1):23-29. PubMed ID: 17967721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia.
    Clauw DJ
    Med Hypotheses; 1995 May; 44(5):369-78. PubMed ID: 8583967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The central cannabinoid receptor type-2 (CB2) and chronic pain.
    Shang Y; Tang Y
    Int J Neurosci; 2017 Sep; 127(9):812-823. PubMed ID: 27842450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroendocrine mechanisms in fibromyalgia-chronic fatigue.
    Buskila D; Press J
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):747-58. PubMed ID: 11812019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychosocial Vulnerability and Early Life Adversity as Risk Factors for Central Sensitivity Syndromes.
    Jones GT
    Curr Rheumatol Rev; 2016; 12(2):140-53. PubMed ID: 26717947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibromyalgia, sleep disorder and chronic fatigue syndrome.
    Moldofsky H
    Ciba Found Symp; 1993; 173():262-71; discussion 272-9. PubMed ID: 8491102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.